Technology | March 18, 2009

FDA Clears Use of Bioptic’s Radiography System in Core Biopsy Analysis

March 18, 2009 – Bioptics Inc., which develops imaging technology for the detection and treatment of cancer, announced at the NCBC 2009 annual conference that the FDA has granted it 510(k) clearance to use the Core VISION, a specimen radiography system, to analyze Core Biopsy samples.

The Core VISION is small, simple to operate and has been ergonomically designed to speed the workflow during biopsy procedures and the results can be readily viewed by various clinicians through their standard PACS network and offers the highest resolution of any product in its class. The Core VISION is radiation shielded, interlocked and can be readily deployed in stereotactic procedure rooms.

“The Core VISION complements our range of specimen radiography products and greatly enhances workflow during core biopsy procedures at a very cost effective price,” said Market Development Manager Cheryl Augello.

For more information: www.bioptics-inc.com

Related Content

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...
Nanox secures $26M supported by strategic investment from Foxconn, unveiling the Startek-inspired AI Biobed for early detection
News | X-Ray | January 16, 2020
January 16, 2020 — Nanox, an innovative medical imaging techn
Carestream’s X-ray digital tomosynthesis functionality creates three-dimensional datasets from digital radiography (DR) that can be scrolled through similar to computed tomography (CT) imaging. It received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in January 2020. Digital tomosynthesis uses a single sweep of X-ray exposures and streamlines operator workflow by separating the process of DT exposure acquisition from image volume formation.
News | Digital Radiography (DR) | January 15, 2020
January 15, 2020 — Carestream’s X-ray digital tomosynthesis (DT) functionality, which creates three-dimensional datas
Sponsored Content | Videos | Digital Radiography (DR) | January 06, 2020
An experienced technologist and two Agfa executives talk about what distinguishes the new Agfa 100s.
 Piedmont Rockdale Hospital
News | Mobile Devices | December 19, 2019
December 19, 2019 — Piedmont Rockdale Hospital (Conyers, Ga.), a healthcare provider with a Level III Neonatal Intens
Videos | RSNA | December 18, 2019
ITN Editor Dave Fornell and ITN Consulting Editor Greg Freiherr offer a post-game report on the trends and technologi
The Hitachi Scenaria View CT scanner on display at the 2019 Radiological Society of North America (RSNA) meeting in December. This workhorse 64 or 128 slice CT system, and Hitchai's portfolio of MRI and ultrasound systems, is attracting the attention of Fujifilm, which does not have some of these technologies. Combined, the new new portfolio may help Fufifilm capture a parger portion of international radiology market share. Photo by Dave Fornell.

The Hitachi Scenaria View CT scanner on display at the 2019 Radiological Society of North America (RSNA) meeting in December. This workhorse 64 or 128 slice CT system, and Hitchai's portfolio of MRI and ultrasound systems, is attracting the attention of Fujifilm, which does not have some of these technologies. Combined, the new new portfolio may help Fujifilm capture a larger portion of international radiology market share. Photo by Dave Fornell.

Feature | Radiology Business | December 17, 2019 | Dave Fornell, Editor
December 17, 2019 — It was disclosed today that Fujifilm may buy Hitachi's diagnostic imaging business in a deal that
#RSNA19 A sophisticated type of artificial intelligence (AI) can detect clinically meaningful chest X-ray findings as effectively as experienced radiologists, according to a study published in the journal Radiology.

Image courtesy of GE Healthcare

News | Artificial Intelligence | December 03, 2019
December 3, 2019 — A sophisticated type of...